Ethics and transparency
Creating positive societal impact and promote ethical behaviour in all markets across our value chain
Women in Management: Career Level F (senior middle management) or higher
of employees feel that AstraZeneca is a great place to work
instances of non-compliance with the Code of Ethics per thousand employees in commercial regions
of supplier spend was assessed through our third-party risk management (3PRM) process
of our employees feel AstraZeneca has a Speak Up culture
of our sites actively promote three or more of our four Essential Health Activities: healthy eating and drinking, physical activity, tobacco cessation and workplace pressure management
365备用网址APPWe strive to model an ethical business culture by going above and beyond legal requirements. This means fostering an environment where our employees can speak up if they have questions or encounter wrongdoing.
Recognizing that our workforce is composed of individuals empowered to make their own decisions, we know that setting rules is not enough—which is why we emphasise culture and key principles. We foster this culture by encouraging all employees to adopt a sustainability mindset that embraces one of our core values of 'doing the right thing' for all our partners. In 2017, we relaunched our Code of Ethics to strengthen employee understanding by outlining our commitments in simple terms and focusing on why these commitments matter. The updated Code comprises our Company Values, expected behaviours and Global Policies. Additional requirements at the global, local and business-unit level complement our Code, providing clear guidance for employees in carrying out their daily work.
Our Ethics and transparency focus areas include:
Our Ethics and transparency approach supports the following Sustainable Development Goals (SDGs)
Animals in Science
At AstraZeneca we embrace a ‘Culture of Care’. This means we have high standards of animal welfare and constantly look for ways to improve how we use animals in science. We are committed to the 3Rs in our research – Replacement, Reduction, and Refinement.
365备用网址APPWe have a Council for Science and Animal Welfare (C-SAW), the expert decision-making group, which oversees the use of animals in science, ensuring our oversight mechanisms are robust, and ensuring that we continually improve laboratory animal science and welfare.
Learn more about our approach to Bioethics here.
See our Bioethics Policy to learn more
365备用网址APPClinical trials are used to study the effects of potential new medicines in humans. They are critical to developing new life-saving medicines. We are continually working to be transparent with our data from clinical trials.
365备用网址APPVisit our for information on results from our clinical trials. This industry-wide portal was driven by AstraZeneca, in collaboration with a vendor partner. It is first of its kind, developed with input from patients.
See our Bioethics Policy 365备用网址APPto learn more
Approach to Taxation
Our business activities around the world incur a substantial amount and variety of taxes. The taxes we pay and collect represent a significant contribution to the countries and societies in which we operate.
See our Approach to Taxation policy to learn more.
AstraZeneca is committed to expanding access to healthcare through intellectual property and to providing transparency about where our patents are filed and enforced.
See our Intellectual Property statement to learn more about our approach, to view the list of countries where we do not file patent applications, and to view patent rights for medicines used to treat Index diseases.
Human Biological Samples
The use of human biological samples, such as solid tissue, biofluids and their derivatives, plays a vital role in developing a deeper understanding of human diseases, which helps us develop effective, new and precision medicines as well as improved diagnoses.
When we conduct this research, we employ processes to ensure that we maintain high ethical standards. We place an emphasis on informed consent that protects the rights and expectations of donors and families.
Learn more about our approach to Bioethics here.
See our Bioethics Policy to learn more.
Our Sustainability Data Summary shows the numbers on this topic.
Interactive Transparency Map launched
We’re boosting our efforts in transparency. We've launched a new interactive tool to increase our openness around sourcing, manufacturing, site programmes and access to healthcare programmes involved in delivering our medicines to patients. This is a step on our sustainability journey. It puts our Value of doing the right thing into action.
Our professional interactions are transparent
By providing visibility into the details of financial arrangements with HCPs and HCOs, AstraZeneca hopes to foster a greater understanding of the value, appropriateness, and necessity of relationships between the pharmaceutical industry and HCPs and HCOs – relationships critical to the research and development of new medicines and to vital exchanges of information within the broader medical community. For more information as well as a view of our disclosure reports, click on the link below.